Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Other Working Capital Changes (2019 - 2025)

Biodesix (BDSX) has disclosed Other Working Capital Changes for 7 consecutive years, with $732000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes rose 2118.18% year-over-year to $732000.0, compared with a TTM value of $258000.0 through Dec 2025, down 63.92%, and an annual FY2025 reading of $258000.0, down 63.92% over the prior year.
  • Other Working Capital Changes was $732000.0 for Q4 2025 at Biodesix, up from -$360000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $1.8 million in Q3 2024 and bottomed at -$1.2 million in Q3 2022.
  • Average Other Working Capital Changes over 5 years is -$118200.0, with a median of -$160000.0 recorded in 2023.
  • The sharpest move saw Other Working Capital Changes crashed 817.65% in 2024, then soared 2118.18% in 2025.
  • Year by year, Other Working Capital Changes stood at $403000.0 in 2021, then soared by 62.53% to $655000.0 in 2022, then plummeted by 179.08% to -$518000.0 in 2023, then skyrocketed by 106.37% to $33000.0 in 2024, then skyrocketed by 2118.18% to $732000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for BDSX at $732000.0 in Q4 2025, -$360000.0 in Q3 2025, and $101000.0 in Q2 2025.